These interesting observations underscore the importance of personalized medicine, and the need for characterizing normal breast and mammary tumour epithelial expression of PPARγ before considering TZD-like drugs as chemotherapeutic strategies for breast cancer patients. Here, PPARG is linked to breast carcinoma.